Knowledge, attitude, and practice associated with antibiotic use among university students: a survey in Nepal P Shah, R Shrestha, Z Mao, Y Chen, Y Chen, P Koju, X Liu, H Li International journal of environmental research and public health 16 (20), 3996, 2019 | 61 | 2019 |
Association between child abuse and health risk behaviors among Chinese college students Y Chen, X Liu, Y Huang, H Yu, S Yuan, Y Ye, Q Li, Q He Journal of child and family studies 26, 1380-1387, 2017 | 38 | 2017 |
Higher contraceptive uptake in HIV treatment centers offering integrated family planning services: a national survey in Kenya Y Chen, E Begnel, W Muthigani, D Achwoka, CJ Mcgrath, B Singa, ... Contraception 102 (1), 39-45, 2020 | 17 | 2020 |
The health and economic impact of constructing temporary field hospitals to meet the COVID-19 pandemic surge: Wuhan Leishenshan Hospital in China as a case study Y Cai, Y Chen, L Xiao, S Khor, T Liu, Y Han, Y Yuan, L Cai, G Zeng, ... Journal of Global Health 11, 2021 | 15 | 2021 |
Impact of the pilot volume-based drug purchasing policy in China: Interrupted time-series analysis with controls Y Chen, X Ji, H Xiao, JM Unger, Y Cai, Z Mao, K Yeung Frontiers in Pharmacology 12, 804237, 2021 | 14 | 2021 |
Microvascular benefits of new antidiabetic agents: a systematic review and network meta-analysis of kidney outcomes AS Cha, Y Chen, K Fazioli, MB Rivara, EB Devine The Journal of Clinical Endocrinology & Metabolism 106 (4), 1225-1234, 2021 | 11 | 2021 |
An interactive text messaging intervention to improve adherence to option B+ prevention of mother-to-child HIV transmission in Kenya: cost analysis Y Chen, K Ronen, D Matemo, JA Unger, J Kinuthia, G John-Stewart, ... JMIR mHealth and uHealth 8 (10), e18351, 2020 | 7 | 2020 |
Designing a value-based formulary for a commercial health plan: A simulated case study of diabetes medications Y Chen, AR Loucks, SD Sullivan, SD Pearson, D Kent, K Yeung Value in Health 26 (7), 1022-1031, 2023 | 6* | 2023 |
Cost-effectiveness analysis of double low-dose budesonide and low-dose budesonide plus montelukast among pediatric patients with persistent asthma receiving Step 3 treatment in … X Wang, H Fang, K Shen, T Liu, J Xie, Y Liu, P Wu, Y Chen, J Zhong, ... Journal of Medical Economics 23 (12), 1630-1639, 2020 | 6 | 2020 |
Real-World Biomarker Test Utilization and Subsequent Treatment in Patients with Early-Stage Non-small Cell Lung Cancer in the United States, 2011− 2021 JT Yan, Y Jin, E Lo, Y Chen, AE Hanlon Newell, Y Kong, LJ Inge Oncology and Therapy 11 (3), 343-360, 2023 | 5 | 2023 |
Health care costs and resource use of managing hemophilia A: A targeted literature review Y Chen, SJ Cheng, T Thornhill, P Solari, SD Sullivan Journal of Managed Care & Specialty Pharmacy 29 (6), 647-658, 2023 | 5 | 2023 |
Key learnings from Institute for Clinical and Economic Review’s real-world evidence reassessment pilot A Jaksa, L Bloudek, JJ Carlson, K Shah, Y Chen, AR Patrick, A McKenna, ... International journal of technology assessment in health care 38 (1), e32, 2022 | 4 | 2022 |
Assessing preferences for HIV pre-exposure prophylaxis (PrEP) delivery services via online pharmacies in Kenya: protocol for a discrete choice experiment Y Chen, EM Saldarriaga, MA Montano, K Ngure, N Thuo, C Kiptinness, ... BMJ open 13 (4), e069195, 2023 | 2 | 2023 |
The effectiveness and value of tirzepatide for type 2 diabetes mellitus: A Summary from the Institute for Clinical and Economic Review’s New England Comparative Effectiveness … D Nikitin, GA Lin, JD Campbell, RN Hansen, E Brouwer, Y Chen, ... Journal of Managed Care & Specialty Pharmacy 28 (6), 680-684, 2022 | 2 | 2022 |
Performance-based risk-sharing arrangements for devices and diagnostics in the United States: a systematic review Y Chen, JJ Carlson Journal of Managed Care & Specialty Pharmacy 28 (1), 78-83, 2022 | 2* | 2022 |
Using machine learning to leverage biomarker change and predict colorectal cancer recurrence PJ Rodriguez, PJ Heagerty, S Clark, S Khor, Y Chen, E Haupt, EE Hahn, ... JCO Clinical Cancer Informatics 7, e2300066, 2023 | 1 | 2023 |
AI2 the impact of including race and ethnicity in risk prediction models on racial bias S Khor, EE Hahn, EC Haupt, V Shankaran, S Clark, P Rodriguez, Y Chen, ... Value in Health 24, S1, 2021 | 1 | 2021 |
Tackling Challenges in Assessing the Economic Value of Tumor-Agnostic Therapies: A Cost-Effectiveness Analysis of Pembrolizumab as a Case Study Y Chen, P Martin, LYT Inoue, A Basu, JJ Carlson Value in Health, 2024 | | 2024 |
RWD19 Comparative Effectiveness Using External Controls for Single-Arm Trials of Pembrolizumab in Tumor-Agnostic Indications Leveraging Real-World Data Y Chen, P Martin, S Ye, L Inoue, A Basu, JJ Carlson Value in Health 26 (6), S363-S364, 2023 | | 2023 |
MT51 Increased Real-World Biomarker Test Utilization in Patients with Early-Stage Non-Small Cell Lung Cancer in the United States, 2011 to 2021 J Yan, Y Jin, E Lo, Y Chen, HN AE, Y Kong, L Inge Value in Health 26 (6), S306, 2023 | | 2023 |